Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.

Biotechnology

Collaboration

Health Care

Therapeutics

Adimab

Adimab's headquarters in Lebanon, NH, United States

Philip Chase

Eric Krauland

Aaron Sato

Marianne Huger Thomson

Max Vásquez

Ryan McGovern

Guy Van Meter

Tillman U. Gerngross

The Research and Development team at Adimab is dedicated to advancing antibody discovery and optimization through cutting-edge research and innovative methodologies. Comprised of a diverse group of scientists and research associates, the team focuses on engineering full-length human Immunoglobulin Gs, employing techniques in protein analytics, computational biology, and bioprocess engineering to enhance the efficacy and performance of therapeutic antibodies. Their collaborative efforts drive the continuous improvement of antibody technologies to meet the evolving needs of the biopharmaceutical industry.

Research and Development

The Leadership Team at Adimab is responsible for setting the strategic direction and ensuring the successful operation of the company. This team, composed of key executives including the President & Chief Scientific Officer, CEO, and CFO, collaborates to drive innovation in antibody discovery, foster strategic partnerships, and oversee financial performance, positioning Adimab as a leader in the biopharmaceutical industry.

Adimab

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Offices

Adimab

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Offices

Related companies